Opthea Limited stock is up 62.21% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 11 December’s closed higher than November.
Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME.